U.S. Online Retail and Ecommerce Stock News

Salesforce (NYSE:CRM) reported a data breach involving unauthorized access to customer CRM records through its integration with competitive-intelligence vendor Klue. The company stated that the incident was confined to the Klue app connection rather than a direct vulnerability in Salesforce’s core platform. Separately, Salesforce agreed to acquire AI agent platform provider Fin in a US$3.6 billion deal to support its Agentforce offering. For investors watching Salesforce, the twin headlines...

Chicago has filed a lawsuit against Airbnb, alleging the company allowed unregistered short term rentals that violate city rules. The legal action targets properties that Chicago claims are operating outside its shared housing and licensing framework. The case raises questions about Airbnb’s compliance processes in one of the largest US urban markets. For investors watching Airbnb, ticker NasdaqGS:ABNB, this lawsuit adds a fresh regulatory angle to consider alongside recent share...

Honeywell International (NasdaqGS:HON) is set to complete its Aerospace spin-off, with Honeywell Aerospace Inc. joining the S&P 500 and S&P 100. Post-spin, the remaining company will be renamed Honeywell Technologies and will stay in the S&P 500. The index changes align with a broader reshuffling in the Dow Jones indices and reflect Honeywell's evolving corporate identity. The rebalancing affects how index tracker funds and benchmarked portfolios gain exposure to Honeywell's aerospace and...

Hewlett Packard Enterprise (NYSE:HPE) and quantum control specialist Qblox have announced a collaboration to link Qblox hardware with HPE high performance computing and AI systems. The partners aim to support hybrid classical quantum computing, including system level benchmarking and co design of hybrid algorithms for scientific and industrial workloads. The move extends HPE activity beyond its usual AI and infrastructure focus into quantum classical integration, an area that has attracted...

PJT Partners (PJT) is back in focus after recent share price moves left the stock roughly flat over the past month but higher over the past three months, prompting renewed interest in its advisory-driven business model. See our latest analysis for PJT Partners. Looking beyond the recent consolidation, PJT Partners’ 11.64% 90 day share price return contrasts with a decline of 10.12% for the year to date. The 3 year total shareholder return of 120.31% and 5 year total shareholder return of...

AMC Entertainment Holdings (AMC) is under renewed scrutiny as investors weigh its recent share price swings and ongoing losses against reported revenue of $5,031.8 million and a market value of about $1.5 billion. See our latest analysis for AMC Entertainment Holdings. At a share price of $1.89, AMC Entertainment Holdings has seen sharp swings, with a 7 day share price return down 33.22% but a 90 day share price return up 99.33%. The 1 year total shareholder return is down 37.42%, indicating...

Earlier in 2026, Cabot Corporation released its 2026 Sustainability Report, revealing it met 14 of 15 2025 sustainability goals, with 11 achieved ahead of schedule and highlighting sharp reductions in nonhazardous landfill waste. The report also outlined early progress toward Cabot’s 2030 Sustainability Goals, including work on product carbon footprints and beneficial reuse of materials, signaling how environmental performance is being embedded into the company’s operations. We’ll now...

If you are wondering whether Republic Services stock is priced fairly today or carrying a premium, this article walks through the key valuation angles that matter to long term investors. After a recent close at US$213.50, the stock shows mixed return signals, with gains of 4.2% over 7 days and 3.1% over 30 days, alongside a 1.6% return year to date but a decline of 11.8% over the past year. These moves sit against a longer track record where the stock has returned 46.0% over 3 years and...

Bladex (NYSE:BLX) has drawn fresh attention after recent trading left the stock at US$61.94, with returns over the past month and past 3 months outpacing its single day decline. See our latest analysis for Bladex. Looking beyond the latest pullback, Bladex has seen a 7 day share price return of 2.92% and a 30 day share price return of 11.18%. Its 1 year total shareholder return of 58.55% and 5 year total shareholder return of more than 4x suggest momentum has been building over a longer...

AI governance launch puts BlackLine stock in focus BlackLine (BL) has drawn fresh attention after introducing a Finance Control Console within its Agentic Financial Operations Platform, a new layer aimed at governance, risk monitoring, and oversight of AI-driven finance workflows. The preview program for this console invites large customers and partners to test capabilities such as real-time observability, policy enforcement, and audit trails, giving investors a concrete product update to...

TE Connectivity (TEL) is back in focus after reporting record quarterly orders of $5.3b, up 25% year over year, alongside mixed analyst reactions tied to valuation and expectations for AI data center demand. See our latest analysis for TE Connectivity. TE Connectivity’s share price has eased recently, with a 7 day share price return of down 8.1% and a year to date share price return of down 14.2%. However, the 1 year total shareholder return is 20.0% and the 5 year total shareholder return is...

American Water Works Company Stock Snapshot After Recent Moves American Water Works Company (AWK) has seen its stock move in different directions across recent periods, with gains over the past week and month set against declines over the past 3 months and year. For investors tracking utilities, these mixed returns, alongside reported annual revenue of US$5.21b and net income of US$1.10b, frame the current discussion around American Water Works Company shares and their recent performance. See...

Iovance Biotherapeutics recently received conditional approval from Australia’s Therapeutic Goods Administration for its advanced melanoma cell therapy Amtagvi, marking its third global marketing authorization after the US and Canada. This milestone opens access to the world’s highest-melanoma-rate market and aligns with Iovance’s broader efforts to expand international commercialization of its TIL-based therapies. We’ll now examine how entering Australia’s high-melanoma market could...

Molson Coors Beverage (TAP) is back in focus after recent share price moves left the stock down about 17% year to date and about 11% over the past 12 months, prompting fresh interest in its valuation. See our latest analysis for Molson Coors Beverage. At a latest share price of US$40.54, Molson Coors Beverage has seen short term share price momentum soften, with the 30 day return down 1.67% and the 90 day return down 6.59%, while the 1 year total shareholder return is down 10.5%. This points...

H.B. Fuller (FUL) has just posted Q2 2026 results with revenue of US$950.3 million, Basic EPS of US$1.25 and net income excluding extra items of US$67.8 million, giving investors a clear look at how the business is performing at mid year. The company has seen quarterly revenue move from US$898.1 million in Q2 2025 to US$950.3 million in Q2 2026, while Basic EPS shifted from US$0.77 to US$1.25 over the same period. This sets the stage for investors to focus on how these results feed through to...

Polaris (NYSE:PII) has secured long-term funding dedicated to outdoor recreation initiatives across America's National Forests. The company announced that its Polaris Fund for Outdoor Recreation Grants is now fully endowed, providing ongoing support for conservation, access, and stewardship projects. Polaris also appointed Dustin J. Semach to its Board of Directors, adding industry and financial experience at an important moment for its governance. Polaris, known for its off-road vehicles,...

In June 2026, IMU Biosciences announced a partnership with Waters Corporation to combine Waters Biosciences' advanced flow cytometry and single‑cell platforms with IMU's AI‑driven High Definition Immunology analytics to enable real‑time, large‑scale immune system profiling across research and clinical settings. This collaboration aims to help establish a universal standard for immune profiling by pairing Waters' hardware and reagents with IMU's machine‑learning platform and expanding IMU's...

If you are trying to work out whether Vornado Realty Trust at around US$38 per share looks expensive or appealing, the key question is how its current price stacks up against a fair value estimate. The stock has recent returns of 0.7% over 7 days, 16.5% over 30 days, 13.8% year to date, 4.8% over 1 year, a very large gain over 3 years and a 5.0% decline over 5 years, which gives a mixed picture of momentum and risk. Recent news around office real estate, including ongoing debate about long...

Major long-term institutional investors, including Berkshire Hathaway and Appaloosa Management, have exited or cut positions in UnitedHealth Group (NYSE:UNH). These moves come as UnitedHealth Group plans to reduce Medicare Advantage membership by 2 million to 3 million lives. The membership pullback follows negative federal oversight findings related to care and claim denials within Medicare Advantage. UnitedHealth Group sits at the center of US managed care, with Medicare Advantage a key...

Earlier in 2026, CarGurus, the most visited automotive shopping site in the U.S., released its Mid-Year Review showing resilient consumer demand, with full-size luxury SUVs above US$80,000 selling faster than the average new vehicle and used hybrids seeing strong year-to-date sales and record prices. The report highlights a shift in buyer preferences toward high-priced luxury SUVs and efficiency-focused used hybrids, underlining how changing consumer mix is reshaping inventory turnover and...

Earlier this week, UMH Properties, Inc. voiced strong support for the bipartisan 21st Century ROAD to Housing Act, highlighting provisions such as removing the permanent chassis requirement, updating FHA Title I financing, and easing zoning barriers for manufactured housing. The company’s leadership framed this legislation as a potential catalyst for expanding its manufactured home communities and enhancing housing options for American families, which could be particularly relevant for...

Earlier this week, ARS Pharmaceuticals reported that neffy, its epinephrine nasal spray, did not gain any new major commercial insurance coverage in the July 1, 2026 review cycle, though the company did secure additional Medicaid coverage and reduced its planned 2026 cash-based operating expenses. The update also included management’s reaffirmation that the existing neffy business underpins a path to cash-flow break-even in 2027, underscoring how payer access remains central to the company’s...

Moog (MOG.A) is in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings, with leadership describing record financial performance and stronger execution across the business. See our latest analysis for Moog. Moog’s recent earnings surprise has come alongside strong share price momentum, with a 30-day share price return of 21.5% and a year-to-date share price return of 66.6%, while the 1-year total shareholder return of 127.6% points to...

In June 2026, Helus Pharma reported that enrollment in Cybin’s APPROACH Phase 3 trial of HLP003 for adjunctive major depressive disorder surpassed 86%, advancing a program that holds FDA Breakthrough Therapy Designation and builds on earlier positive Phase 2 clinical outcomes. This late-stage progress, alongside previously reported long-term efficacy signals, highlights how HLP003 could further shape Cybin’s pipeline profile if Phase 3 results are supportive. We’ll now examine how this...